Insider Transactions in Q1 2026 at Ionis Pharmaceuticals Inc (IONS)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2026
|
Shannon L. Devers EVP, Chief Human Resources Ofc |
SELL
Open market or private sale
|
Direct |
3,977
-15.0%
|
$322,137
$81.34 P/Share
|
|
Jan 16
2026
|
Brett P Monia Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
44,034
-16.39%
|
$3,258,516
$74.82 P/Share
|
|
Jan 16
2026
|
Patrick R. O'Neil EVP CLO & General Counsel |
SELL
Open market or private sale
|
Direct |
9,191
-12.2%
|
$689,325
$75.84 P/Share
|
|
Jan 16
2026
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
SELL
Open market or private sale
|
Direct |
9,302
-12.71%
|
$697,650
$75.59 P/Share
|
|
Jan 16
2026
|
Eric Swayze EVP Research |
SELL
Open market or private sale
|
Indirect |
49
-13.35%
|
$3,675
$75.97 P/Share
|
|
Jan 16
2026
|
Eric Swayze EVP Research |
SELL
Open market or private sale
|
Direct |
9,884
-19.07%
|
$741,300
$75.34 P/Share
|
|
Jan 16
2026
|
Joseph Baroldi EVP, Chief Business Officer |
SELL
Open market or private sale
|
Indirect |
1,149
-19.41%
|
$86,175
$75.78 P/Share
|
|
Jan 16
2026
|
Joseph Baroldi EVP, Chief Business Officer |
SELL
Open market or private sale
|
Direct |
6,907
-14.59%
|
$518,025
$75.75 P/Share
|
|
Jan 16
2026
|
C Frank Bennett EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,977
-8.65%
|
$673,275
$75.15 P/Share
|
|
Jan 16
2026
|
Brian Birchler EVP, Corp and Development Ops |
SELL
Open market or private sale
|
Direct |
8,480
-12.31%
|
$636,000
$75.11 P/Share
|
|
Jan 16
2026
|
Shannon L. Devers EVP, Chief Human Resources Ofc |
SELL
Open market or private sale
|
Direct |
8,353
-23.95%
|
$626,475
$75.95 P/Share
|
|
Jan 16
2026
|
Elizabeth L Hougen EVP, Finance & CFO |
SELL
Open market or private sale
|
Direct |
12,922
-9.28%
|
$969,150
$75.22 P/Share
|
|
Jan 16
2026
|
Kyle Jenne EVP, Chf GL Pdt Str Ofcr |
SELL
Open market or private sale
|
Direct |
1,823
-10.01%
|
$136,725
$75.96 P/Share
|
|
Jan 16
2026
|
Holly B. Kordasiewicz EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
4,141
-21.96%
|
$310,575
$75.66 P/Share
|
|
Jan 15
2026
|
Brett P Monia Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
89,145
+24.91%
|
-
|
|
Jan 15
2026
|
Patrick R. O'Neil EVP CLO & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
21,473
+22.17%
|
-
|
|
Jan 15
2026
|
Eugene Schneider EVP, Chf Clinical Develop Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
21,685
+22.86%
|
-
|
|
Jan 15
2026
|
Eric Swayze EVP Research |
BUY
Exercise of conversion of derivative security
|
Indirect |
111
+23.22%
|
-
|
|
Jan 15
2026
|
Eric Swayze EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
21,366
+29.19%
|
-
|
|
Jan 15
2026
|
Michael J. Yang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,930
+19.55%
|
-
|
|
Jan 15
2026
|
Joseph Baroldi EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,850
+32.49%
|
-
|
|
Jan 15
2026
|
Joseph Baroldi EVP, Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,037
+26.47%
|
-
|
|
Jan 15
2026
|
C Frank Bennett EVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,055
+16.87%
|
-
|
|
Jan 15
2026
|
Brian Birchler EVP, Corp and Development Ops |
BUY
Exercise of conversion of derivative security
|
Direct |
20,089
+22.57%
|
-
|
|
Jan 15
2026
|
Shannon L. Devers EVP, Chief Human Resources Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
17,377
+33.26%
|
-
|
|
Jan 15
2026
|
Elizabeth L Hougen EVP, Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,729
+17.1%
|
-
|
|
Jan 15
2026
|
Kyle Jenne EVP, Chf GL Pdt Str Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
7,013
+27.8%
|
-
|
|
Jan 15
2026
|
Holly B. Kordasiewicz EVP, Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,119
+37.09%
|
-
|
|
Jan 07
2026
|
Shannon L. Devers EVP, Chief Human Resources Ofc |
SELL
Open market or private sale
|
Direct |
44,199
-27.83%
|
$3,712,716
$84.92 P/Share
|
|
Jan 07
2026
|
Shannon L. Devers EVP, Chief Human Resources Ofc |
BUY
Exercise of conversion of derivative security
|
Direct |
44,199
+20.41%
|
$1,856,358
$42.49 P/Share
|
|
Jan 02
2026
|
Eric Swayze EVP Research |
SELL
Open market or private sale
|
Direct |
23,463
-25.99%
|
$1,830,114
$78.92 P/Share
|
|
Jan 02
2026
|
Eric Swayze EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
23,463
+19.95%
|
$1,407,780
$60.89 P/Share
|